Shares of FibroGen fell by a staggering 61.85% in 30 days from $57.72 to $22.02 at 20:15 EST on Monday, following the last session’s downward trend. NASDAQ Composite is falling 0.48% to $13,895.12, following the last session’s downward trend,
FibroGen’s last close was $22.32, 159.81% under its 52-week high of $57.21.
The company’s growth estimates for the current quarter and the next is 2.2% and 51.6%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $22.02 at 20:15 EST, way under its 52-week high of $57.21 and higher than its 52-week low of $21.97.
FibroGen’s Moving Average
FibroGen’s value is way under its 50-day moving average of $39.14 and way below its 200-day moving average of $42.31.
More news about FibroGen.